Nomura Holdings »

Taysha Gene Therapies shares owned by Nomura Holdings

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Nomura Holdings from 13F filings

Historical chart of Nomura Holdings investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Nomura Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Nomura Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.4M 259k 5.50

More positions owned by Nomura Holdings

Echostar Corp Note 3.875%11/3
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Alibaba Group Hldg Note 0.500% 6/0
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation (MSFT)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amazon (AMZN)
Pepsi (PEP)
Dollar Tree (DLTR)
Palantir Technologies Cl A (PLTR)

View all positions for Nomura Holdings

Top funds holding Taysha Gene Therapies

RA Capital Management
venBio Select Advisor
BlackRock
Rtw Investments
FMR
Vestal Point Capital
Goldman Sachs Group
Vanguard Group
State Street Corporation
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays
Geode Capital Management
Millennium Management

View all funds holding Taysha Gene Therapies